Literature DB >> 2642434

Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion.

S Bonner-Weir1, D Deery, J L Leahy, G C Weir.   

Abstract

The extent to which adult pancreatic beta-cells can respond in vivo to a sustained glucose stimulus by increasing their mass through either hyperplasia or hypertrophy has remained unanswered. Therefore, we studied the in vivo effect of short-term (96-h) hyperglycemia on the growth of beta-cells by infusing adult rats with 35 or 50% glucose or 0.45% saline. After 96 h of glucose infusion, the beta-cell mass, quantified by point-counting morphometrics of immunoperoxidase-stained paraffin sections, showed a 50% increase (9.57 +/- 0.87 mg, n = 5, 50% glucose infused; 9.50 +/- 1.23, n = 7, 35% glucose infused; 6.15 +/- 0.55, n = 6, 0.45% saline infused). This growth was selective for beta-cells; the non-beta-cell mass was unchanged. The mitotic index, measured by accumulated mitotic frequency after a 4-h colchicine treatment, increased fivefold in glucose-infused animals compared to saline-infused animals. This enhanced replication of beta-cells provides evidence for increase in cell number or hyperplasia. In addition, hypertrophy of the beta-cell was also quantified. Mean cell volume, determined from the mean cell cross-sectional area measured planimetrically from low-magnification electron micrographs, increased to 150% of control values after 96 h of 50% glucose infusion. Seven days after the 96-h infusion, in reversal experiments, the beta-cell mass had not returned to saline-infused levels. In addition, the non-beta-cell mass of glucose-infused animals had increased. The mitotic index of the beta-cell of glucose-infused rats was, however, significantly lower than that of the saline controls, but the mean cell volume of the beta-cells remained elevated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642434     DOI: 10.2337/diab.38.1.49

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  148 in total

1.  Excitation wave propagation as a possible mechanism for signal transmission in pancreatic islets of Langerhans.

Authors:  O V Aslanidi; O A Mornev; O Skyggebjerg; P Arkhammar; O Thastrup; M P Sørensen; P L Christiansen; K Conradsen; A C Scott
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

2.  cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

Authors:  Ulupi S Jhala; Gianluca Canettieri; Robert A Screaton; Rohit N Kulkarni; Stan Krajewski; John Reed; John Walker; Xueying Lin; Morris White; Marc Montminy
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

3.  Insulin secretion and insulin-producing tumors.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Expert Rev Endocrinol Metab       Date:  2010-03-01

4.  Human beta cell proliferation by glucose--a complex scenario.

Authors:  M Tiedge
Journal:  Diabetologia       Date:  2010-12-21       Impact factor: 10.122

5.  Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult rat pancreas.

Authors:  M Chintinne; G Stangé; B Denys; P In 't Veld; K Hellemans; M Pipeleers-Marichal; Z Ling; D Pipeleers
Journal:  Diabetologia       Date:  2010-07-20       Impact factor: 10.122

Review 6.  Development, growth and maintenance of β-cell mass: models are also part of the story.

Authors:  Anmar Khadra; Santiago Schnell
Journal:  Mol Aspects Med       Date:  2015-02-23

7.  Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets.

Authors:  Derek K Hagman; Martin G Latour; Swarup K Chakrabarti; Ghislaine Fontes; Julie Amyot; Caroline Tremblay; Meriem Semache; James A Lausier; Violet Roskens; Raghavendra G Mirmira; Thomas L Jetton; Vincent Poitout
Journal:  Diabetes       Date:  2007-11-08       Impact factor: 9.461

8.  Insulin demand regulates β cell number via the unfolded protein response.

Authors:  Rohit B Sharma; Amy C O'Donnell; Rachel E Stamateris; Binh Ha; Karen M McCloskey; Paul R Reynolds; Peter Arvan; Laura C Alonso
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

Review 9.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

10.  Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat model of type 2 diabetes.

Authors:  S Calderari; M-N Gangnerau; M Thibault; M-J Meile; N Kassis; C Alvarez; B Portha; P Serradas
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.